Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes

{ 'indexed': {'date-parts': [[2022, 1, 19]], 'date-time': '2022-01-19T17:23:07Z', 'timestamp': 1642612987928}, 'reference-count': 44, 'publisher': 'Springer Science and Business Media LLC', 'license': [ { 'start': { 'date-parts': [[2022, 1, 18]], 'date-time': '2022-01-18T00:00:00Z', 'timestamp': 1642464000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2022, 1, 18]], 'date-time': '2022-01-18T00:00:00Z', 'timestamp': 1642464000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'funder': [{'name': 'Platelet and Thrombosis Research'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'short-container-title': ['J Thromb Thrombolysis'], 'DOI': '10.1007/s11239-022-02631-7', 'type': 'journal-article', 'created': {'date-parts': [[2022, 1, 18]], 'date-time': '2022-01-18T09:22:57Z', 'timestamp': 1642497777000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': [ 'Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, ' 'and thrombotic risk markers and better clinical outcomes'], 'prefix': '10.1007', 'author': [ {'given': 'Abira', 'family': 'Usman', 'sequence': 'first', 'affiliation': []}, {'given': 'Kevin P.', 'family': 'Bliden', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alastair', 'family': 'Cho', 'sequence': 'additional', 'affiliation': []}, {'given': 'Naval', 'family': 'Walia', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christophe', 'family': 'Jerjian', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arvind', 'family': 'Singh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Parshotam', 'family': 'Kundan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sanchit', 'family': 'Duhan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Udaya S.', 'family': 'Tantry', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-5461-568X', 'authenticated-orcid': False, 'given': 'Paul A.', 'family': 'Gurbel', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2022, 1, 18]]}, 'reference': [ { 'key': '2631_CR1', 'doi-asserted-by': 'crossref', 'first-page': '782', 'DOI': '10.1016/S2213-8587(20)30238-2', 'volume': '8', 'author': 'M Apicella', 'year': '2020', 'unstructured': 'Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S ' '(2020) COVID-19 in people with diabetes: understanding the reasons for ' 'worse outcomes. Lancet Diabetes Endocrinol 8:782–792', 'journal-title': 'Lancet Diabetes Endocrinol'}, { 'key': '2631_CR2', 'doi-asserted-by': 'crossref', 'first-page': '215', 'DOI': '10.4239/wjd.v12.i3.215', 'volume': '12', 'author': 'V Viswanathan', 'year': '2021', 'unstructured': 'Viswanathan V, Puvvula A, Jamthikar AD et al (2021) Bidirectional link ' 'between diabetes mellitus and coronavirus disease 2019 leading to ' 'cardiovascular disease: a narrative review. World J Diabetes 12:215–237', 'journal-title': 'World J Diabetes'}, { 'key': '2631_CR3', 'doi-asserted-by': 'crossref', 'first-page': '1966', 'DOI': '10.1136/bmj.m1966', 'volume': '369', 'author': 'CM Petrilli', 'year': '2020', 'unstructured': 'Petrilli CM, Jones SA, Yang J (2020) Factors associated with ' 'hospitalization and critical illness among 4,103 patients with COVID-19 ' 'disease in New York City. BMJ 369:1966', 'journal-title': 'BMJ'}, { 'key': '2631_CR4', 'doi-asserted-by': 'crossref', 'first-page': '104354', 'DOI': '10.1016/j.jcv.2020.104354', 'volume': '127', 'author': 'L Roncon', 'year': '2020', 'unstructured': 'Roncon L, Zuin M, Rigatelli G, Zuliani G (2020) Diabetic patients with ' 'COVID-19 infection are at higher risk of ICU admission and poor ' 'short-term outcome. J Clin Virol 127:104354', 'journal-title': 'J Clin Virol'}, { 'key': '2631_CR5', 'doi-asserted-by': 'crossref', 'unstructured': 'Saha S, Al-Rifai RH, Saha S (2021) Diabetes prevalence and mortality in ' 'COVID-19 patients: a systematic review, meta-analysis, and ' 'meta-regression. J Diabetes Metab Disord 1–12', 'DOI': '10.1007/s40200-021-00779-2'}, { 'key': '2631_CR6', 'doi-asserted-by': 'crossref', 'first-page': '108561', 'DOI': '10.1016/j.diabres.2020.108561', 'volume': '171', 'author': 'G Lazarus', 'year': '2021', 'unstructured': 'Lazarus G, Audrey J, Wangsaputra VK et al (2021) High admission blood ' 'glucose independently predicts poor prognosis in COVID-19 patients: a ' 'systematic review and dose-response meta-analysis. Diabetes Res Clin ' 'Pract 171:108561', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '2631_CR7', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.4269/ajtmh.20-0375', 'volume': '103', 'author': 'P Luo', 'year': '2020', 'unstructured': 'Luo P, Qiu L, Liu Y et al (2020) Metformin treatment was associated with ' 'decreased mortality in COVID-19 patients with diabetes in a ' 'retrospective analysis. Am J Trop Med Hyg 103:69–72', 'journal-title': 'Am J Trop Med Hyg'}, { 'key': '2631_CR8', 'doi-asserted-by': 'crossref', 'first-page': '2177', 'DOI': '10.1016/j.dsx.2020.11.006', 'volume': '14', 'author': 'AA Lukito', 'year': '2020', 'unstructured': 'Lukito AA, Pranata R, Henrina J et al (2020) The effect of metformin ' 'consumption on mortality in hospitalized COVID-19 patients: a systematic ' 'review and meta-analysis. Diabetes Metab Syndr 14:2177–2183', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '2631_CR9', 'doi-asserted-by': 'crossref', 'first-page': '293', 'DOI': '10.1016/S2213-8587(21)00050-4', 'volume': '9', 'author': 'K Khunti', 'year': '2021', 'unstructured': 'Khunti K, Knighton P, Zaccardi F et al (2021) Prescription of ' 'glucose-lowering therapies and risk of COVID-19 mortality in people with ' 'type 2 diabetes: a nationwide observational study in England. Lancet ' 'Diabetes Endocrinol 9:293–303', 'journal-title': 'Lancet Diabetes Endocrinol'}, { 'key': '2631_CR10', 'doi-asserted-by': 'crossref', 'first-page': '513', 'DOI': '10.1016/j.dsx.2021.02.022', 'volume': '15', 'author': 'R Ghany', 'year': '2021', 'unstructured': 'Ghany R, Palacio A, Dawkins E et al (2021) Metformin is associated with ' 'lower hospitalizations, mortality and severe coronavirus infection among ' 'elderly medicare minority patients in 8 states in USA. Diabetes Metab ' 'Syndr 15:513–518', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '2631_CR11', 'doi-asserted-by': 'crossref', 'first-page': '623', 'DOI': '10.4049/jimmunol.1700474', 'volume': '200', 'author': 'C Kajiwara', 'year': '2018', 'unstructured': 'Kajiwara C, Kusaka Y, Kimura S et al (2018) Metformin mediates ' 'protection against legionella pneumonia through activation of AMPK and ' 'mitochondrial reactive oxygen species. J Immunol 200:623–631', 'journal-title': 'J Immunol'}, { 'key': '2631_CR12', 'doi-asserted-by': 'crossref', 'first-page': '20348', 'DOI': '10.1074/jbc.M115.662114', 'volume': '290', 'author': 'B Kelly', 'year': '2015', 'unstructured': 'Kelly B, Tannahill GM, Murphy MP, O’Neill LAJ (2015) Metformin inhibits ' 'the production of reactive oxygen species from NADH: ubiquinone ' 'oxidoreductase to limit induction of Interleukin-1b (IL-1b) and boosts ' 'Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated ' 'macrophages. J Biol Chem 290:20348–20359', 'journal-title': 'J Biol Chem'}, { 'key': '2631_CR13', 'doi-asserted-by': 'crossref', 'first-page': '2596', 'DOI': '10.3390/ijms22052596', 'volume': '22', 'author': 'H Kaneto', 'year': '2021', 'unstructured': 'Kaneto H, Kimura T, Obata A et al (2021) Multifaceted mechanisms of ' 'action of metformin which have been unraveled one after another in the ' 'long history. Int J Mol Sci 22:2596', 'journal-title': 'Int J Mol Sci'}, { 'key': '2631_CR14', 'doi-asserted-by': 'crossref', 'first-page': '539', 'DOI': '10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S', 'volume': '15', 'author': 'KG Alberti', 'year': '1998', 'unstructured': 'Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of ' 'diabetes mellitus and its complications. Part 1: diagnosis and ' 'classification of diabetes mellitus provisional report of a WHO ' 'consultation. Diabet Med 15:539–553', 'journal-title': 'Diabet Med'}, { 'key': '2631_CR15', 'doi-asserted-by': 'crossref', 'first-page': '642', 'DOI': '10.3109/09537104.2016.1153617', 'volume': '27', 'author': 'PA Gurbel', 'year': '2016', 'unstructured': 'Gurbel PA, Bliden KP, Tantry US et al (2016) First report of the ' 'point-of-care TEG: a technical validation study of the TEG-6S system. ' 'Platelets 27:642–649', 'journal-title': 'Platelets'}, { 'key': '2631_CR16', 'doi-asserted-by': 'publisher', 'author': 'PA Gurbel', 'year': '2020', 'unstructured': 'Gurbel PA, Bliden KP, Tantry US (2020) Defining platelet response to ' 'acetylsalicylic acid: the relation between inhibition of serum ' 'thromboxane B2 and agonist-induced platelet aggregation. J Thromb ' 'Thrombolysis. https://doi.org/10.1007/s11239-020-02334-x', 'journal-title': 'J Thromb Thrombolysis', 'DOI': '10.1007/s11239-020-02334-x'}, { 'key': '2631_CR17', 'doi-asserted-by': 'crossref', 'first-page': '68', 'DOI': '10.5551/jat.13.68', 'volume': '13', 'author': 'K Endo', 'year': '2006', 'unstructured': 'Endo K, Miyashita Y, Sasaki H et al (2006) Probucol and atorvastatin ' 'decrease urinary 8-hydroxy-2’-deoxyguanosine in patients with diabetes ' 'and hypercholesterolemia. J Atheroscler Thromb 13:68–75', 'journal-title': 'J Atheroscler Thromb'}, { 'key': '2631_CR18', 'doi-asserted-by': 'crossref', 'first-page': '577', 'DOI': '10.1016/j.athoracsur.2011.10.048', 'volume': '93', 'author': 'D Katagiri', 'year': '2012', 'unstructured': 'Katagiri D, Doi K, Honda K, Negishi K et al (2012) Combination of two ' 'urinary biomarkers predicts acute kidney injury after adult cardiac ' 'surgery. Ann Thorac Surg 93:577–583', 'journal-title': 'Ann Thorac Surg'}, { 'key': '2631_CR19', 'doi-asserted-by': 'crossref', 'first-page': '20', 'DOI': '10.1080/00325481.2020.1823094', 'volume': '133', 'author': 'G White-Dzuro', 'year': '2021', 'unstructured': 'White-Dzuro G, Gibson LE, Zazzeron L et al (2021) Multisystem effects of ' 'COVID-19: a concise review for practitioners. Postgrad Med 133:20–27', 'journal-title': 'Postgrad Med'}, { 'key': '2631_CR20', 'doi-asserted-by': 'crossref', 'first-page': '193', 'DOI': '10.1007/s00592-009-0109-4', 'volume': '47', 'author': 'JK Yang', 'year': '2010', 'unstructured': 'Yang JK, Lin SS, Ji XJ, Guo LM (2010) Binding of SARS coronavirus to its ' 'receptor damages islets and causes acute diabetes. Acta Diabetol ' '47:193–199', 'journal-title': 'Acta Diabetol'}, { 'key': '2631_CR21', 'doi-asserted-by': 'crossref', 'first-page': '535', 'DOI': '10.1016/j.dsx.2020.04.044', 'volume': '14', 'author': 'A Kumar', 'year': '2020', 'unstructured': 'Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, ' 'Srivastava A (2020) Is diabetes mellitus associated with mortality and ' 'severity of COVID-19? A meta-analysis. Diabetes Metab Syndr 14:535–545', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '2631_CR22', 'doi-asserted-by': 'crossref', 'first-page': '1068', 'DOI': '10.1016/j.cmet.2020.04.021', 'volume': '31', 'author': 'L Zhu', 'year': '2020', 'unstructured': 'Zhu L, She Z-G, Cheng X et al (2020) Association of blood glucose ' 'control and outcomes in patients with COVID-19 and pre-existing type 2 ' 'diabetes. Cell Metab 31:1068–1077', 'journal-title': 'Cell Metab'}, { 'key': '2631_CR23', 'doi-asserted-by': 'crossref', 'first-page': '823', 'DOI': '10.1016/S2213-8587(20)30271-0', 'volume': '8', 'author': 'N Holman', 'year': '2020', 'unstructured': 'Holman N, Knighton P, Kar P et al (2020) Risk factors for ' 'COVID-19-related mortality in people with type 1 and type 2 diabetes in ' 'England: a population-based cohort study. Lancet Diabetes Endocrinol ' '8:823–833', 'journal-title': 'Lancet Diabetes Endocrinol'}, { 'key': '2631_CR24', 'doi-asserted-by': 'crossref', 'first-page': '600439', 'DOI': '10.3389/fendo.2020.600439', 'volume': '11', 'author': 'AB Crouse', 'year': '2021', 'unstructured': 'Crouse AB, Grimes T, Li P et al (2021) Metformin use is associated with ' 'reduced mortality in a diverse population with COVID-19 and diabetes. ' 'Front Endocrinol 11:600439', 'journal-title': 'Front Endocrinol'}, { 'key': '2631_CR25', 'doi-asserted-by': 'crossref', 'unstructured': 'Samuel SM, Varghese E, Büsselberg D (2021) Therapeutic potential of ' 'metformin in COVID-19: reasoning for its protective role. Trends ' 'Microbiol. S0966–842X(21)00063–9', 'DOI': '10.1016/j.tim.2021.03.004'}, { 'key': '2631_CR26', 'doi-asserted-by': 'crossref', 'first-page': '854', 'DOI': '10.1016/S0140-6736(98)07037-8', 'volume': '352', 'author': 'UK Prospective Diabetes Study (UKPDS) Group', 'year': '1998', 'unstructured': 'UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive ' 'blood-glucose control with metformin on complications in overweight ' 'patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865', 'journal-title': 'Lancet'}, { 'key': '2631_CR27', 'doi-asserted-by': 'crossref', 'first-page': '622262', 'DOI': '10.3389/fphar.2021.622262', 'volume': '12', 'author': 'B Bai', 'year': '2021', 'unstructured': 'Bai B, Chen H (2021) Metformin: a novel weapon against inflammation. ' 'Front Pharmacol 12:622262', 'journal-title': 'Front Pharmacol'}, { 'key': '2631_CR28', 'doi-asserted-by': 'crossref', 'first-page': '34', 'DOI': '10.1186/s12950-016-0142-3', 'volume': '13', 'author': 'W Chen', 'year': '2016', 'unstructured': 'Chen W, Liu X, Ye S (2016) Effects of metformin on blood and urine ' 'pro-inflammatory mediators in patients with type 2 diabetes. J Inflamm ' '(Lond) 13:34', 'journal-title': 'J Inflamm (Lond)'}, { 'key': '2631_CR29', 'doi-asserted-by': 'crossref', 'first-page': '1399', 'DOI': '10.2337/dc20-0660', 'volume': '43', 'author': 'Y Chen', 'year': '2020', 'unstructured': 'Chen Y, Yang D, Cheng B et al (2020) Clinical characteristics and ' 'outcomes of patients with diabetes and COVID-19 in association with ' 'glucose-lowering medication. Diabetes Care 43:1399–1407', 'journal-title': 'Diabetes Care'}, { 'key': '2631_CR30', 'first-page': 'e928236', 'volume': '26', 'author': 'K Torigoe', 'year': '2020', 'unstructured': 'Torigoe K, Muta K, Tsuji K et al (2020) Urinary liver-type fatty ' 'acid-binding protein predicts residual renal function decline in ' 'patients on peritoneal dialysis. Med Sci Monit 26:e928236', 'journal-title': 'Med Sci Monit'}, { 'issue': '1154–59', 'key': '2631_CR31', 'first-page': '25', 'volume': '174', 'author': 'K Negishi', 'year': '2009', 'unstructured': 'Negishi K, Noiri E, Doi K et al (2009) Monitoring of urinary L-type ' 'fatty acid-binding protein predicts histological severity of acute ' 'kidney injury. Am J Pathol 174(1154–59):25', 'journal-title': 'Am J Pathol'}, { 'key': '2631_CR32', 'doi-asserted-by': 'crossref', 'first-page': 'e0170', 'DOI': '10.1097/CCE.0000000000000170', 'volume': '2', 'author': 'D Katagiri', 'year': '2020', 'unstructured': 'Katagiri D, Ishikane M, Asai Y et al (2020) Evaluation of coronavirus ' 'disease 2019 severity using urine biomarkers. Crit Care Explor 2:e0170', 'journal-title': 'Crit Care Explor'}, { 'key': '2631_CR33', 'doi-asserted-by': 'crossref', 'first-page': '141', 'DOI': '10.1016/j.pcad.2009.05.001', 'volume': '52', 'author': 'US Tantry', 'year': '2009', 'unstructured': 'Tantry US, Mahla E, Gurbel PA (2009) Aspirin resistance. Prog Cardiovasc ' 'Dis 52:141–152', 'journal-title': 'Prog Cardiovasc Dis'}, { 'key': '2631_CR34', 'doi-asserted-by': 'crossref', 'first-page': '1650', 'DOI': '10.1161/01.CIR.0000013777.21160.07', 'volume': '105', 'author': 'JW Eikelboom', 'year': '2002', 'unstructured': 'Eikelboom JW, Hirsh J, Weitz JI et al (2002) Aspirin-resistant ' 'thromboxane biosynthesis and the risk of myocardial infarction, stroke, ' 'or cardiovascular death in patients at high risk for cardiovascular ' 'events. Circulation 105:1650–1655', 'journal-title': 'Circulation'}, { 'key': '2631_CR35', 'doi-asserted-by': 'crossref', 'first-page': '1705', 'DOI': '10.1161/CIRCULATIONAHA.108.768283', 'volume': '118', 'author': 'JW Eikelboom', 'year': '2008', 'unstructured': 'Eikelboom JW, Hankey GJ, Thom J et al (2008) Clopidogrel for High ' 'Atherothrombotic Risk and Ischemic Stabilization, Management and ' 'Avoidance (CHARISMA) Investigators. Incomplete inhibition of thromboxane ' 'biosynthesis by acetylsalicylic acid: determinants and effect on ' 'cardiovascular risk. Circulation 118:1705–1712', 'journal-title': 'Circulation'}, { 'issue': '2', 'key': '2631_CR36', 'first-page': 'ehaa946', 'volume': '41', 'author': 'B Rocca', 'year': '2020', 'unstructured': 'Rocca B, Buck G, Petrucci G et al (2020) Thromboxane metabolite ' 'excretion is associated with serious vascular events in diabetes ' 'mellitus: a sub-study of the ASCEND trial. Eur Heart J 41(2):ehaa946', 'journal-title': 'Eur Heart J'}, { 'key': '2631_CR37', 'doi-asserted-by': 'crossref', 'first-page': '3743', 'DOI': '10.3390/ijms21113743', 'volume': '21', 'author': 'M Graille', 'year': '2020', 'unstructured': 'Graille M, Wild P, Sauvain JJ et al (2020) Urinary 8-OHdG as a biomarker ' 'for oxidative stress: a systematic literature review and meta-analysis. ' 'Int J Mol Sci 21:3743', 'journal-title': 'Int J Mol Sci'}, { 'key': '2631_CR38', 'doi-asserted-by': 'crossref', 'first-page': '667', 'DOI': '10.1016/j.jacc.2013.03.089', 'volume': '62', 'author': 'D Tousoulis', 'year': '2013', 'unstructured': 'Tousoulis D, Papageorgiou N, Androulakis E, et al (2013) Diabetes ' 'mellitus-associated vascular impairment: novel circulating biomarkers ' 'and therapeutic approaches. J Am Coll Cardiol 62:667–676', 'journal-title': 'J Am Coll Cardiol'}, { 'key': '2631_CR39', 'doi-asserted-by': 'crossref', 'first-page': '548', 'DOI': '10.1089/ars.2015.6508', 'volume': '24', 'author': 'A Di Minno', 'year': '2016', 'unstructured': 'Di Minno A, Turnu L, Porro B et al (2016) 8-Hydroxy-2-deoxyguanosine ' 'levels and cardiovascular disease: a systematic review and meta-analysis ' 'of the literature. Antioxid Redox Signal 24:548–555', 'journal-title': 'Antioxid Redox Signal'}, { 'key': '2631_CR40', 'doi-asserted-by': 'crossref', 'first-page': '120', 'DOI': '10.1080/10590500902885684', 'volume': '27', 'author': 'A Valavanidis', 'year': '2009', 'unstructured': 'Valavanidis A, Vlachogianni T, Fiotakis C et al (2009) ' '“8-Hydroxy2’-deoxyguanosine (8-OHdG): a critical biomarker of oxidative ' 'stress and carcinogenesis. J Environ Sci Health C 27:120–139', 'journal-title': 'J Environ Sci Health C'}, { 'key': '2631_CR41', 'doi-asserted-by': 'crossref', 'first-page': '5953685', 'DOI': '10.1155/2019/5953685', 'volume': '2019', 'author': 'E Bigagli', 'year': '2019', 'unstructured': 'Bigagli E, Lodovici M (2019) Circulating oxidative stress biomarkers in ' 'clinical studies on type 2 diabetes and its complications. Oxid Med Cell ' 'Longev 2019:5953685', 'journal-title': 'Oxid Med Cell Longev'}, { 'key': '2631_CR42', 'doi-asserted-by': 'crossref', 'first-page': '423', 'DOI': '10.1016/j.diabet.2020.07.006', 'volume': '46', 'author': 'AJ Scheen', 'year': '2020', 'unstructured': 'Scheen AJ (2020) Metformin and COVID-19: from cellular mechanisms to ' 'reduced mortality. Diabetes Metab 46:423–426', 'journal-title': 'Diabetes Metab'}, { 'key': '2631_CR43', 'doi-asserted-by': 'crossref', 'first-page': '101216', 'DOI': '10.1016/j.diabet.2020.101216', 'volume': '47', 'author': 'JD Lalau', 'year': '2021', 'unstructured': 'Lalau JD, Al-Salameh A, Hadjadj S et al (2021) Metformin use is ' 'associated with a reduced risk of mortality in patients with diabetes ' 'hospitalised for COVID-19. Diabetes Metab 47:101216', 'journal-title': 'Diabetes Metab'}, { 'issue': '21', 'key': '2631_CR44', 'first-page': '00167', 'volume': 'S0188–4409', 'author': 'T Han', 'year': '2021', 'unstructured': 'Han T, Ma S, Sun C et al (2021) The association between anti-diabetic ' 'agents and clinical outcomes of COVID-19 in patients with diabetes: a ' 'systematic review and meta-analysis. Arch Med Res ' 'S0188–4409(21):00167–00173', 'journal-title': 'Arch Med Res'}], 'container-title': ['Journal of Thrombosis and Thrombolysis'], 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s11239-022-02631-7.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s11239-022-02631-7/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s11239-022-02631-7.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 1, 18]], 'date-time': '2022-01-18T10:11:27Z', 'timestamp': 1642500687000}, 'score': 1, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 1, 18]]}, 'references-count': 44, 'alternative-id': ['2631'], 'URL': 'http://dx.doi.org/10.1007/s11239-022-02631-7', 'relation': {}, 'ISSN': ['0929-5305', '1573-742X'], 'issn-type': [{'value': '0929-5305', 'type': 'print'}, {'value': '1573-742X', 'type': 'electronic'}], 'subject': ['Cardiology and Cardiovascular Medicine', 'Hematology'], 'published': {'date-parts': [[2022, 1, 18]]}, 'assertion': [ { 'value': '30 December 2021', 'order': 1, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '18 January 2022', 'order': 2, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'Dr. Gurbel reports grants and personal fees from Bayer HealthCare LLC, Otitopic ' 'Inc, Amgen, Janssen, and US WorldMeds LLC; grants from Instrumentation ' 'Laboratory, Haemonetics, Medicure Inc, Idorsia Pharmaceuticals, and Hikari Dx; ' 'personal fees from UpToDate; Dr Gurbel is a relator and expert witness in ' 'litigation involving clopidogrel; in addition, Dr. Gurbel has two patents, ' 'Detection of restenosis risk in patients issued and Assessment of cardiac ' 'health and thrombotic risk in a patient. Dr. Tantry reports receiving honoraria ' 'from UptoDate and Aggredyne. Other authors report no disclosures.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of interest'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}